Thursday, June 20, 2024

Indian Covaxin approved for emergency use by WHO

Immigration News

Najibullah Lalzoy
Najibullah Lalzoy
Najibullah Lalzoy is a journalist and editor at Khaama Press. He has a BA degree in journalism.

World Health Organization has temporarily approved India’s home-grown anti-corona vaccine for emergency use that is a step forward to the official approval of the vaccine.

The vaccine that is the latest added to the emergency list of WHO’s COVID- vaccines are produced by Bharat Biotech and is named Covaxin.

World Health Organization’s Strategic Advisory Group of Experts said that the vaccine had outweighed risks and added that it meets their standards for protection against the pandemic.

The group of experts has suggested the vaccine to be used in two doses with intervals of one month for people age 18 or above.

The decision by WHO will help millions of people who have been given the vaccine but due to lack of international approval of the vaccine the people were not authorized to travel abroad.

Millions of Indians have been stuck at their homes now for nearly one year who are doing jobs out of India.

The move will likewise help WHO’s COVAX international program that is aimed at providing vaccines to the entire world in particular to poor people.

- Advertisement -

More articles


Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!

- Advertisement -

The World News